|We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. For example, here is how to disable FireFox ad content blocking while on Silicon Investor.|
AASTROM is developing proprietary process technologies and devices for a range of cell therapy applications, including stem cell therapies and gene therapies.
what do ya'll think about this biotech company. it recently ipo'd at $7. it's in the low $6s. the technology niche, if it works, seems to be something of great value. i'd appreciate all input...
|© 2019 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News|